| Q36172703 | A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate |
| Q37654867 | Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain |
| Q34630464 | Anti-inflammatory resuscitation improves survival in hemorrhage with trauma |
| Q36342735 | Bench-to-bedside review: Amelioration of acute renal impairment using ethyl pyruvate. |
| Q35104577 | Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat. |
| Q42734436 | Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation. |
| Q45983944 | Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. |
| Q36076963 | Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate |
| Q39203952 | Current concepts in the management of acute pancreatitis |
| Q95362919 | Diclofenac Sodium Treatment Ameliorates Extrapancreatic Organ Injuries in a Murine Model of Acute Pancreatitis Induced by Caerulein |
| Q38937361 | EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells. |
| Q35834151 | Effects of ethyl pyruvate on leukocyte-endothelial interactions in the mesenteric microcirculation during early sepsis treatment. |
| Q42459469 | Ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expression |
| Q41864669 | Ethyl pyruvate inhibits retinal pathogenic neovascularization by downregulating HMGB1 expression |
| Q28068263 | Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries |
| Q40884597 | Ethyl pyruvate modulates acute inflammatory reactions in human endothelial cells in relation to the NF-kappaB pathway |
| Q40509411 | Ethyl pyruvate prevents methyglyoxal-induced retinal vascular injury in rats |
| Q33665291 | Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms |
| Q46209458 | Ethyl pyruvate protects colonic anastomosis from ischemia-reperfusion injury |
| Q36093484 | Ethyl pyruvate reduces liver injury at early phase but impairs regeneration at late phase in acetaminophen overdose |
| Q42062324 | Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model. |
| Q34779056 | Fluid resuscitation in acute pancreatitis. |
| Q39186586 | HMGB1 and Histones Play a Significant Role in Inducing Systemic Inflammation and Multiple Organ Dysfunctions in Severe Acute Pancreatitis. |
| Q35141090 | HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity |
| Q33618428 | HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma |
| Q35045701 | High-mobility group box 1 protein and its role in severe acute pancreatitis |
| Q35223589 | Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate |
| Q39641003 | Interaction of ethyl pyruvate in vitro with NF-κB subunits, RelA and p50 |
| Q37018467 | Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. |
| Q33664210 | NSAIDs and Acute Pancreatitis: A Systematic Review |
| Q33295511 | Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis |
| Q58088351 | Prophylactic effect of ethyl pyruvate on renal ischemia/reperfusion injury mediated through oxidative stress |
| Q43537710 | Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia |
| Q34994107 | Scientific and clinical challenges in sepsis |
| Q47095662 | The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). |
| Q47153310 | Trypsinogen Activation Peptide Induces HMGB1 Release from Rat Pancreatic Acinar Cells |